|
|||||
|
|
Resistance profile of the human immunodeficiency virus type 1 reverse transcriptase inhibitor abacavir (1592U89) after monotherapy and combination therapy. CNA2001 Investigative Group |
|
| Authors: | Harrigan P R Stone C Griffin P Nájera I Bloor S Kemp S Tisdale M Larder B |
| Affiliation: | Clinical Virology, GlaxoWellcome Research and Development, Stevenage, United Kingdom. |
| Abstract: | |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |